Researchers have identified a potential pathway that could protect heart function in people with Duchenne muscular dystrophy. Duchenne muscular dystrophy (DMD) is a progressive and fatal genetic disease that weakens the body’s muscles. “The results are very promising.” Published in Molecular Therapy, the new study examined the effects of the experimental drug Setanaxib in two preclinical models of DMD. Researchers found that the treatment preser…